We emphasize the balance between clinical efficacy and financial considerations
And our current thinking about obesity, and one of the components of the disease of obesity, is that some individuals although they all have GLP-1 and these other gut hormones, amylin, glucagon, GIP, that's what they're called that signal, for some reason, is not getting to the brain in ample amounts to tell the individual to feel full, satiated, and stop eating
Some people may prefer a daily pill over a weekly injection
Backed by data, supported by your provider, and adjusted based on your bodys responses, the progress you make isnt fragile